Trial intelligence / Profile preview

Egalet Carvedilol vs Immediate-Release Carvedilol in Hypertension

NCT00444834Phase 2Terminated

Sponsor
Egalet
Start
Apr 2007
Primary completion
May 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of carvedilol in hypertension (HTN), sponsored by Egalet. Started Apr 2007; status: terminated.

02

Drugs

carvedilol
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT00444834.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00444834.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call